BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
0.335
-0.210 (-38.59%)
Nov 21, 2024, 1:57 PM EST - Market open
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $44.57 million as of November 21, 2024. Its market cap has decreased by -53.57% in one year.
Market Cap
44.57M
Enterprise Value
35.71M
1-Year Change
-53.57%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since July 27, 2011, BioLineRx's market cap has decreased from $62.20M to $44.57M, a decrease of -28.34%. That is a compound annual growth rate of -2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 42.80M | -55.97% |
| Dec 29, 2023 | 97.20M | 167.77% |
| Dec 30, 2022 | 36.30M | -62.34% |
| Dec 31, 2021 | 96.40M | 93.57% |
| Dec 31, 2020 | 49.80M | 123.32% |
| Dec 31, 2019 | 22.30M | -51.42% |
| Dec 31, 2018 | 45.90M | -58.65% |
| Dec 29, 2017 | 111.00M | 120.24% |
| Dec 30, 2016 | 50.40M | -0.98% |
| Dec 31, 2015 | 50.90M | 30.18% |
| Dec 31, 2014 | 39.10M | -24.22% |
| Dec 31, 2013 | 51.60M | 64.86% |
| Dec 31, 2012 | 31.30M | -20.15% |
| Dec 30, 2011 | 39.20M | -36.98% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeueHealth | 40.85M |
| iCAD, Inc. | 40.72M |
| Reviva Pharmaceuticals Holdings | 40.63M |
| Intensity Therapeutics | 40.63M |
| Verrica Pharmaceuticals | 40.47M |
| Accelerate Diagnostics | 40.25M |
| Nexalin Technology | 40.23M |
| LAVA Therapeutics | 39.97M |